XML 48 R20.htm IDEA: XBRL DOCUMENT v3.6.0.2
STOCK BASED COMPENSATION
12 Months Ended
Dec. 31, 2016
STOCK BASED COMPENSATION  
STOCK BASED COMPENSATION

NOTE 12 STOCK BASED COMPENSATION

Stock Options

The Plan allows for equity awards to be granted to employees, consultants, advisors, and directors. The Plan is administered by the Board of Directors, which determines the terms pursuant to which any award is granted. The Board of Directors may delegate to certain officers the authority to grant awards to certain employees (other than such officers), consultants and advisors.    The number of shares of common stock reserved for issuance thereunder is 17.5 million shares, with no more than 1 million shares subject to grants of options to an individual in a calendar year. The plan also provides for the grant of incentive options under Section 422 of the Internal Revenue Code (the “Code”), which provide potential tax benefits to the recipients compared to non-qualified options. At December 31, 2016, 5,294,563 awards were authorized and available for issuance under the Plan.

During the year ended December 31, 2016, 1,494,085 shares of common stock were issued upon exercise of stock options under the Company’s Amended and Restated Equity Incentive Plan (“Plan”), at a weighted average exercise price of $2.51 per share for proceeds of $3.7 million. This compares to no shares of common stock issues during 2015 and 1,499,300 shares of common stock issued during 2014 upon exercise at a weighted average exercise price of $1.29 per share, for proceeds of $1.9 million.

The following table summarizes information about stock options under the Plan outstanding at December 31, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted

    

 

 

 

 

 

 

Weighted

 

Average

 

 

 

 

 

 

 

Average

 

Remaining

 

 

 

 

 

Number of

 

Exercise

 

Contractual

 

Intrinsic

 

 

Shares

 

Price

 

Life (Years)

 

Value

 

 

(in thousands, except per share and year data)

Balance at December 31, 2014

 

4,651

 

$

3.35

 

4.4

 

$

 —

Granted

 

2,733

 

 

1.03

 

 —

 

 

 —

Exercised

 

 —

 

 

 —

 

 —

 

 

 —

Forfeited

 

(272)

 

 

2.82

 

 —

 

 

 —

Expired

 

(158)

 

 

2.12

 

 —

 

 

 —

Balance at December 31, 2015

 

6,954

 

$

2.49

 

4.1

 

$

98

Granted

 

645

 

 

3.99

 

 —

 

 

 —

Exercised

 

(1,457)

 

 

2.48

 

 —

 

 

1,601

Forfeited

 

(1,422)

 

 

3.45

 

 —

 

 

 —

Expired

 

 —

 

 

 —

 

 —

 

 

 —

Balance at December 31, 2016

 

4,720

 

$

2.41

 

3.4

 

$

4,388

Exercisable at December 31, 2016

 

2,257

 

$

2.74

 

2.9

 

$

1,697

 

Stock options have been granted to key employees, directors and consultants under the Plan.  Options to purchase shares under the Plan were granted at or above market value as of the date of the grant.  During the year ended December 31, 2016, the Company granted stock options to certain employees and directors for an aggregate of 0.7 million shares of common stock (2015 -  2.7 million, 2014 -  1.7 million) at a weighted average exercise price of $3.99 per share (2015 – $1.03, 2014 - $2.90). The options vest equally over a three-year period if the individuals remain affiliated with the Company (subject to acceleration of vesting in certain events) and are exercisable for a period of 5 years from the date of issue.

The fair value of the options granted under the Plan was estimated at the date of grant, using the Black-Scholes option-pricing model, with the following weighted-average assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

    

2016

    

2015

    

2014

 

Risk-free interest rate

 

 

1.13% to 1.21%

 

 

1.10% to 1.79%

 

 

1.10

%

Dividend yield

 

 

0.24% to 0.27%

 

 

0% to 1.15%

 

 

 —

%

Volatility factor of the expected market price of common stock

 

 

74%

 

 

73% to 74%

 

 

70

%

Weighted-average expected life of option

 

 

5.0 years

 

 

5.0 years

 

 

3.5 years

 

Weighted-average grant date fair value

 

$

2.36

 

$

0.49

 

$

1.45

 

 

During the year ended December 31, 2016, the Company recorded stock option expense of $1.0 million (2015 -$1.3 million, 2014 - $1.3 million) while the corresponding fair value of awards vesting in the period was $1.3 million (2015 - $1.5 million and 2014 - $2.0 million). None of the stock option expense was capitalized as part of the cost of an asset or any other item on the Consolidated Balance Sheet.

At December 31, 2016, there was $1.4 million (2015 - $1.6 million, 2014 - $1.8 million) of unrecognized compensation expense related to 2.5 million (2015 - 4.2 million, 2014 - 2.7 million) unvested stock options outstanding.  This cost is expected to be recognized over a weighted-average period of approximately 1.6 years (2015 - 1.6 years, 2014 – 1.6 years).

The following table summarizes the status and activity of non-vested stock options for the year ended December 31, 2016: 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

Number of

 

Grant Date

 

    

Shares

    

Fair Value

 

 

(in thousands, except per share amounts)

Non-vested, beginning of year

 

4,182

 

$

0.74

Granted

 

645

 

$

2.36

Cancelled/Forfeited

 

(826)

 

$

0.77

Vested

 

(1,538)

 

$

0.85

Non-vested, end of year

 

2,463

 

$

1.08